Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze COLL stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate COLL investment potential.

What is COLL stock price today?

Get real-time COLL stock price, historical data, and price charts on Financhill. Track COLL performance with our advanced analysis tools.

Is COLL a good investment?

Evaluate COLL investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy COLL stock?

To buy COLL stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of COLL?

View detailed market capitalization data and company valuation metrics for COLL on our comprehensive analysis page.

What is the P/E ratio of COLL?

Use our fundamental analysis tools to view COLL P/E ratio and compare valuation metrics with industry peers.

What are COLL earnings?

View COLL earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Collegium Pharmaceutical, Inc. 10K Form

Buy

COLL
Collegium Pharmaceutical, Inc.

Last Price:

$47.45

Seasonality Move:

9.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-07	10Q	COLL/Collegium Pharmaceutical, Inc. Quarterly
2023-08-03	10Q	COLL/Collegium Pharmaceutical, Inc. Quarterly
2023-05-04	10Q	COLL/Collegium Pharmaceutical, Inc. Quarterly
2022-11-03	10Q	COLL/Collegium Pharmaceutical, Inc. Quarterly
2022-08-04	10Q	COLL/Collegium Pharmaceutical, Inc. Quarterly
2022-05-10	10Q	COLL/Collegium Pharmaceutical, Inc. Quarterly

Receive COLL News And Ratings

See the #1 stock for the next 7 days that we like better than COLL

COLL Financial Statistics

Sales & Book Value

Annual Sales:	$631.4M
Cash Flow:	$78.3M
Price / Cash Flow:	6.26
Annual Sales:	$8.70
Price / Book:	5.5

Profitability

EPS (TTM):	1.60680
Net Income (TTM):	$58.4M
Gross Margin:	$377.3M
Return on Equity:	24.26%
Return on Assets:	3.59%

Collegium Pharmaceutical, Inc. Earnings Forecast

Key Collegium Pharmaceutical, Inc. Financial Ratios

The Gross Profit Margin over the past 11 years for COLL is 59.76%.
The Selling, General & Administrative Expenses for COLL have been equal to 33.31% of Gross Profit Margin.
The Research & Development expenses have been 0.00% of Revenue.
The Interest Expense is 106.91% of Operating Income.
The Net Earning history of COLL is 10.96% of Total Revenues.
Per Share Earnings over the last 12 years have been positive in 8 years.

Collegium Pharmaceutical, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	COLL
CUSIP:	19459J
Website:	collegiumpharma.com

Debt

Debt-to-Equity Ratio:	3.41
Current Ratio:	1.36
Quick Ratio:	1.25

Price-to-Earnings

Trailing P/E Ratio:	25.77
Forward P/E Ratio:	5.93

COLL Technical Analysis vs Fundamental Analysis

Buy

Collegium Pharmaceutical, Inc. (COLL) is a Buy

Is Collegium Pharmaceutical, Inc. a Buy or a Sell?

Collegium Pharmaceutical, Inc. stock is rated a Buy

The current Collegium Pharmaceutical, Inc. [COLL] share price is $47.85. The Score for COLL is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.